Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer

Makohon-Moore, Alvin P, Zhang, Ming, Reiter, Johannes G, Bozic, Ivana, Allen, Benjamin, Kundu, Deepanjan, Chatterjee, Krishnendu, Wong, Fay +12 more·2017·Nature Genetics
DOI 10.1038/ng.3764

Cited by (411)

Items 201–300 of 411

  1. Simple mucinous cysts of the pancreas have heterogeneous somatic mutations
    Marc A. Attiyeh, Lance Zhang, Christine A. Iacobuzio–Donahue, Peter J. Allen, Rami Imam, Olca Baştürk, David S. Klimstra, Carlie Sigel · 2020 · Human Pathology
  2. The mechanobiome: a goldmine for cancer therapeutics
    Eleana Parajón, Alexandra Surcel, Douglas N. Robinson · 2020 · American Journal of Physiology-Cell Physiology
  3. Pancreatic organoids as cancer avatars for true personalized medicine
    Johann Gout, Menar Ekizce, Élodie Roger, Alexander Kleger · 2025 · Advanced Drug Delivery Reviews
  4. Inflammatory networks cultivate cancer cell metastasis to the liver
    Jae Woo Lee, Gregory Lawrence Beatty · 2020 · Cell Cycle
  5. The biology of pancreatic cancer morphology
    Oliver Gene McDonald · 2021 · Pathology
  6. The molecular landscape of pancreatic ductal adenocarcinoma
    Lavanya Sivapalan, Hemant Mahendrakumar Kocher, Helen Ross‐Adams, Claude Chelala · 2022 · Pancreatology
  7. Insights into the metastatic cascade through research autopsies
    Sonya Hessey, Petros Fessas, Simone Zaccaria, Mariam Jamal‐Hanjani, Charles Swanton · 2023 · Trends in cancer
  8. KMT2D links TGF ‐β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity
    Shuang Lu, Hong Sun Kim, Yubo Cao, Karan Bedi, Lili Zhao, Ishwarya Venkata Narayanan, Brian Magnuson, Yumei Gu, Jing Yang, Zhujun Yi et al. · 2023 · International Journal of Cancer
  9. Metastatic organotropism: a brief overview
    Margarida Carrolo, João A. I. Miranda, Guilherme Vilhais, António Quintela, Mário Fontes e Sousa, Diogo Alpuim Costa, Francisco Rodrigues Pinto · 2024 · Frontiers in Oncology
  10. Untangling the genetics from the epigenetics in pancreatic cancer metastasis
    Christopher R. Vakoc, David Arthur Tuveson · 2017 · Nature Genetics
  11. Pancreatic Cancer Genomics 2.0: Profiling Metastases
    Eric Andrew Collisson, Anirban Maitra · 2017 · Cancer Cell
  12. Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatosplenectomy (CDPS) for left-sided pancreatic ductal adenocarcinoma
    Menghua Dai, Hanyu Zhang, Yatong Li, Xing Cheng, Cheng Ding, Quan Liao, Taiping Zhang, Junchao Guo, Qiang Xu, Xianlin Han et al. · 2021 · Surgery Today
  13. The role of glycometabolic plasticity in cancer
    Yuyang Peng, Hui Yang, Song Li · 2021 · Pathology - Research and Practice
  14. Liver metastasis of pancreatic cancer: the new choice at the crossroads
    Zhe Liu, Anjiang Gou, Xingda Wu · 2023 · HepatoBiliary Surgery and Nutrition
  15. Role of Epigenetics in Pancreatic Ductal Adenocarcinoma
    Somnath Pandey, Vineet Kumar Gupta, Shweta Lavania · 2023 · Epigenomics
  16. HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data
    Matthew A. Myers, Brian J. Arnold, Vineet Bansal, Metin Balaban, Katelyn M. Mullen, Simone Zaccaria, Benjamin J. Raphael · 2024 · Genome biology
  17. T cell receptor β‐chain repertoire analysis of tumor‐infiltrating lymphocytes in pancreatic cancer
    Can Cui, Xiuyun Tian, Jianhui Wu, Chaoting Zhang, Qin Tan, Xiaoya Guan, Bin Dong, Min Zhao, Zheming Lu, Chunyi Hao · 2018 · Cancer Science
  18. mRNA vaccine development and applications: A special focus on tumors (Review)
    Bangjie Chen, Yipin Yang, Xinyi Wang, Wenzhi Yang, You Lu, Daoyue Wang, Enba Zhuo, Yanchao Tang, Junhong Su, Guozheng Tang et al. · 2024 · International Journal of Oncology
  19. Upregulation of the ERRγ–VDAC1 axis underlies the molecular pathogenesis of pancreatitis
    Dipanjan Chanda, Themis Thoudam, Ibotombi Singh Sinam, Chae Won Lim, Myeongjin Kim, Jiale Wang, Kyeong‐Min Lee, Jing Ma, Romil Saxena, Jinhyuk Choi et al. · 2023 · Proceedings of the National Academy of Sciences
  20. Research autopsy programmes in oncology: shared experience from 14 centres across the world
    Tatjana Geukens, Marion Maetens, Jody E. Hooper, Steffi Oesterreich, Adrian V. Lee, Lori Miller, Jenny M Atkinson, Margaret Quinn Rosenzweig, Shannon Puhalla, Heather Thorne et al. · 2024 · The Journal of Pathology
  21. Nanotechnology as a Delivery Tool for Precision Cancer Therapies
    Bhawna Sharma, Rachael M. Crist, Pavan P. Adiseshaiah · 2017 · The AAPS Journal
  22. TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors
    Maria Stadheim Eggebø, Julia Heinzelbecker, Heyilimu Palashati, Nicholas Chandler, Trung The Tran, Yingqian Li, Weiwen Yang, Maarja Laos, Isaac Blaas, Even Holth Rustad et al. · 2025 · Nature Immunology
  23. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics
    Célia Cintas, Thibaut Douché, Nicole Therville, Silvia Arcucci, Fernanda Ramos‐Delgado, Céline Basset, Benoît Thibault, Julie Guillermet‐Guibert · 2018 · Cancers
  24. Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology
    Dimosthenis E. Ziogas, Ioannis D Kyrochristos, Dimitrios H Roukos · 2018 · Drug Discovery Today
  25. Reviving the Autopsy for Modern Cancer Evolution Research
    Tamsin J. Robb, Rexson Datquen Tse, Cherie Blenkiron · 2021 · Cancers
  26. Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
    Yolanda Rodrı́guez Gil, Paula Jiménez Sánchez, Raúl Muñoz Velasco, Ana García García, Victor Javier Sanchez-Arevalo Lobo · 2021 · International Journal of Molecular Sciences
  27. Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies
    Kimiyo N. Yamamoto, Akira Nakamura, Lin L. Liu, Shayna Stein, Angela C. Tramontano, Uri Kartoun, Tetsunosuke Shimizu, Yoshihiro H. Inoue, Mitsuhiro Asakuma, Hiroshi Haeno et al. · 2019 · PLoS ONE
  28. Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer
    Li-Yun Ding, Ya‐Chin Hou, I‐Ying Kuo, Ting-Yi Hsu, Tsung-Ching Tsai, Hsiu-Wei Chang, Wei-Yu Hsu, Chih-Chieh Tsao, Chung-Chen Tian, Po‐Shun Wang et al. · 2020 · Clinical Epigenetics
  29. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia
    Victoria K. Spadafora, Benjamin R. Pryce, Alexander R. Oles, Erin E. Talbert, Martin J. Romeo, Silvia G. Vaena, Stefano Berto, Michael C. Ostrowski, Jingxin Wang, Denis C. Guttridge D · 2024 · BMC Cancer
  30. Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma
    Efsevia Vakiani, Ronak H. Shah, Michael F. Berger, Alvin P. Makohon-Moore, Johannes G. Reiter, Irina Ostrovnaya, Marc A. Attiyeh, Andrea Cercek, Jinru Shia, Christine A. Iacobuzio–Donahue et al. · 2017 · Oncotarget
  31. Molecular Alterations Associated with DNA Repair in Pancreatic Adenocarcinoma Are Associated with Sites of Recurrence
    Margaret D. Ferguson, Lei Dong, Jim Y. Wan, Jeremiah Lee Deneve, Paxton Vandiver Dickson, Stephen W. Behrman, David Shibata, Mike G. Martin, Evan Scott Glazer · 2018 · Journal of Gastrointestinal Cancer
  32. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset
    Jeffery Ho, Xiangchun Li, Lin Zhang, Yonghao Liang, Wei Hu, Johnny Chung Wai Yau, Hung Chan, Tony Gin, Matthew T.V. Chan, Gary Tse et al. · 2018 · Seminars in Cancer Biology
  33. Harnessing the Microbiome to Reduce Pancreatic Cancer Burden
    Ana Raquel Bastos, Joana Pereira‐Marques, Rui M. Ferreira, Céu Figueiredo · 2023 · Cancers
  34. RAS internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling
    Andy Nelson, Thomas J. Turbyville, Srisathiyanarayanan Dharmaiah, Megan Rigby, Rendong Yang, Ting-You Wang, John Columbus, Robert M. Stephens, Troy E. Taylor, Drew Sciacca et al. · 2020 · Journal of Biological Chemistry
  35. Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL
    Russell D. Moser, James E. Annis, Olga H. Nikolova, Cliff Whatcott, Kay E. Gurley, Eduardo Méndez, Kim Moran‐Jones, Craig Dorrell, Rosalie C. Sears, Calvin Jay Kuo et al. · 2022 · Cancer Research
  36. Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer
    Nicholas Fraser Brown, Elizabeth R. Murray, Lauren C. Cutmore, Philip W. Howard, Luke A. Masterson, Francesca Zammarchi, John Anthony Hartley, Patrick H. van Berkel, John F. Marshall · 2024 · Pancreatology
  37. Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
    Yutong Zhao, Cheng Qin, Lin Chen, Zeru Li, Bangbo Zhao, Tianyu Li, Xiangyu Zhang, Weibin Wang · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  38. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy
    Emmanuel Salinas-Miranda, Farzad Khalvati, Kashayar Namdar, Dominik Deniffel, Xin Dong, Engy Abbas, Julie M. Wilson, Grainne Mary O'Kane, Jennifer Jane Knox, Steve Gallinger et al. · 2020 · Canadian Association of Radiologists Journal
  39. Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer
    Fumiaki Watanabe, Koichi Suzuki, Hiroshi Noda, Toshiki Rikiyama · 2022 · World Journal of Gastroenterology
  40. The Epigenetic Landscape of Pancreatic Cancer Stem Cells
    Sladjana Zagorac, Laura García‐Bermejo, Bruno Sáinz · 2018 · Epigenomes
  41. Unraveling Tumor Heterogeneity by Using DNA Barcoding Technologies to Develop Personalized Treatment Strategies in Advanced-Stage PDAC
    Philip Dujardin, Anna K. Baginska, Sebastian Urban, Barbara M. Grüner · 2021 · Cancers
  42. Time-Series Analysis of Tumorigenesis in a Murine Skin Carcinogenesis Model
    Yoshimasa Aoto, Kazuhiro Okumura, Tsuyoshi Hachiya, Sumitaka Hase, Yuichi Wakabayashi, Fuyuki Ishikawa, Yasubumi Sakakibara · 2018 · Scientific Reports
  43. Targeting KRAS Inhibitor–Resistant Pancreatic Cancer with an MUC1-C Antibody–Drug Conjugate
    Hiroki Ozawa, Keiko Takahashi, Tomoki Motegi, Justine J. Jacobi, Atrayee Bhattacharya, Keisuke Shigeta, Shinkichi Takamori, Mai Onishi, Zhou Luan, Kazumasa Fukuda et al. · 2025 · Clinical Cancer Research
  44. Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma
    Silvana Debernardi, Łukasz Liszka, Chara Ntala, Katja Steiger, Iréne Esposito, Emanuela Carlotti, Ann‐Marie Baker, Stuart A.C. McDonald, Trevor A. Graham, Branko Dmitrović et al. · 2023 · Molecular Oncology
  45. CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer
    Kota Okuno, Kyonosuke Ikemura, Riku Okamoto, Keiko Oki, Akiko Watanabe, Yu Kuroda, Mikiko Kidachi, Shiori Fujino, Yusuke Nie, Tadashi Higuchi et al. · 2024 · PLoS ONE
  46. The glutathione S-transferase Gstt1 drives survival and dissemination in metastases
    Christina M. Ferrer, Hyo Min Cho, Ruben Boon, Tiziano Bernasocchi, Lai Ping Wong, Murat Çetinbaş, Elizabeth R. Haggerty, Irene Rin Mitsiades, Gregory R. Wojtkiewicz, Daniel E. McLoughlin et al. · 2024 · Nature Cell Biology
  47. Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism
    Shani Journo, Anat Klein Goldberg, Ethan S. Sokol, Lotem Zinger, Metsada Pasmanik, Boris A. Sarvin, Dor Simkin, Sivan Fuchs, Tomer Shlomi, Ido Wolf et al. · 2022 · Oncogene
  48. Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer
    Alexandra Petersson, Natalie Andersson, Sofie Olsson Hau, Jakob Eberhard, Jenny Karlsson, Subhayan Chattopadhyay, Anders Valind, Jacob Elebro, Björn Nodin, Karin Leandersson et al. · 2022 · Molecular Cancer Research
  49. Reprogramming Enhancers to Drive Metastasis
    Raúl Mostoslavsky, Nabeel M. Bardeesy · 2017 · Cell
  50. Deciphering genomic evolution of metastatic organotropism with 535 paired primary lung cancers and metastases
    Duo Xie, Wen‐Fang Tang, Tao Jiang, Hao Duan, Shanlan Mo, Hao Zhang, Xiangwei Zhai, Qingda Tian, Zan Li, Yi Liang et al. · 2025 · Cell Reports
  51. Charting single-cell lineages with synthetic and natural barcodes
    Alejo Rodriguez-Fraticelli, Victoria Parreno · 2026 · Nature Reviews Genetics
  52. PHF13 epigenetically activates TGFβ driven epithelial to mesenchymal transition
    Yating Sun, Dan Li, Hongmei Liu, Yongye Huang, Fanyu Meng, Jiahao Tang, Zhanjun Li, Wanhua Xie · 2022 · Cell Death and Disease
  53. Oncogenic signaling pathways in pancreatic ductal adenocarcinoma
    Rahul Agrawal, Kedar Nath Natarajan · 2023 · Advances in cancer research
  54. Repositioning of Old Drugs for Novel Cancer Therapies: Continuous Therapeutic Perfusion of Aspirin and Oseltamivir Phosphate with Gemcitabine Treatment Disables Tumor Progression, Chemoresistance, and Metastases
    Bessi Qorri, Reza Bayat Mokhtari, William W. Harless, Myron R. Szewczuk · 2022 · Cancers
  55. Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasion
    Alexander T.F. Bell, Peter E. Chianchiano, Katsuya Hirose, Daniel James Salas-Escabillas, Doreen M. Zucha, Jacob T. Mitchell, Ludmila Danilova, Alexander Ioannis Damanakis, Joseph A. Tandurella, Jeanette Johnson et al. · 2025 · Science Translational Medicine
  56. Tumor heterogeneity: An oncogenic driver of PDAC progression and therapy resistance under stress conditions
    António M. Palma, Vignesh Vudatha, Maria Leonor Peixoto, Esha Madan · 2023 · Advances in cancer research
  57. Biologie des métastases et mécanismes moléculaires de leur formation
    Florence Coussy, Florian Bonin, Paula Azorin, Zakia Tariq, Keltouma Driouch · 2018 · Bulletin du Cancer
  58. Post‐mortem tissue donation programs as platforms to accelerate cancer research
    Matthew Dankner, Badia Issa‐Chergui, Nathaniel Bouganim · 2020 · The Journal of Pathology Clinical Research
  59. Demethylzeylasteral suppresses the expression of MESP1 by reducing H3K18la level to inhibit the malignant behaviors of pancreatic cancer
    Xiaolei Ma, Mengxing Cheng, Yanxin Jia, Kun Zhang, Haocheng Zhang, Di Feng, Wenxiao Xu, Guofen Qiao · 2025 · Cell Death Discovery
  60. The Prognostic Value of the EASIX Score in Patients with Metastatic Pancreatic Cancer
    Vahit Can Çavdar, Yalçın Gökmen, Mert Aric, Tugba Altunkaya, Cennet Gizem Erdem, İlkay Gültürk, Çiğdem Usul Afşar · 2025 · Diagnostics
  61. Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
    Alejandro Jiménez-Sánchez, Sitara Persad, Akimasa Hayashi, Shigeaki Umeda, Roshan Sharma, Yubin Xie, Arnav Mehta, Wungki Park, Ignas Masilionis, Tinyi Chu et al. · 2025 · Cancer Research
  62. Selective enhancer changes in osteosarcoma lung metastasis
    Heinrich Kovar · 2018 · Nature Medicine
  63. Accurate Prognosis Prediction of Pancreatic Ductal Adenocarcinoma Using Integrated Clinico-Genomic Data of Endoscopic Ultrasound-Guided Fine Needle Biopsy
    Joo Kyung Park, Hye Min Kim, Dae‐Soon Son, Nayoung K. D. Kim, Young Kyung Sung, Minseob Cho, Chung Lee, Dong Hyo Noh, Se‐Hoon Lee, Kyu Taek Lee et al. · 2021 · Cancers
  64. Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy
    Hunter C. Gits, Amy Tang, William Scott Harmsen, William R. Bamlet, Rondell Patrell Graham, Gloria M. Petersen, Thomas C. Smyrk, Amit Mahipal, Roman O. Kowalchuk, Jonathan B. Ashman et al. · 2021 · Journal of Gastrointestinal Oncology
  65. Three-dimensional genomic mapping of human pancreatic tissue reveals striking multifocality and genetic heterogeneity in precancerous lesions
    Alicia M. Braxton, Ashley L. Kiemen, Mia P. Grahn, André Forjaz, Jaanvi Mahesh Babu, Lily Zheng, Liping Jiang, Haixia Cheng, Qianqian Song, Rebecca Reichel et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer
    Alvaro Curiel-Garcia, Sam R. Holmstrom, Cristina Castillo, Carmine F. Palermo, Stephen A. Sastra, Anthony C. Andren, Lorenzo Tomassoni, Li Zhang, Tessa Y. S. Le Large, Irina R. Sagalovskiy et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Reciprocal tumor‐platelet interaction through the EPHB1‐EFNB1 axis in the liver metastatic niche promotes metastatic tumor outgrowth in pancreatic ductal adenocarcinoma
    Linli Yao, Wei‐Ting Qin, Longgang Hu, Tie‐Zhu Shi, Jian Yu Yang, Qing Li, Hui Nie, Jun Li, Xu Wang, Lei Zhu et al. · 2024 · 癌症：英文版
  68. DNA methylation memory of pancreatic acinar-ductal metaplasia transition state altering Kras-downstream PI3K and Rho GTPase signaling in the absence of Kras mutation
    Emily K.W. Lo, Adrian Idrizi, Rakel Tryggvadóttir, Weiqiang Zhou, Wenpin Hou, Hongkai Ji, Patrick Cahan, Andrew P. Feinberg · 2025 · Genome Medicine
  69. Soils and Seeds That Initiate Pancreatic Cancer Metastasis
    Christopher R. Vakoc, David A. Tuveson · 2017 · Cancer Discovery
  70. Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
    Maroun Bou Zerdan, Malek Shatila, Dhruv Sarwal, Youssef Bouferraa, Morgan Bou Zerdan, Sabine Allam, Merima Ramovic-Zobic, Stephen L. Graziano · 2022 · Cancers
  71. Differential modulation of cellular phenotype and drug sensitivity by extracellular matrix proteins in primary and metastatic pancreatic cancer cells
    Olalekan H. Usman, Sampath Kumar, Reddick Russell Walker, Gengqiang Xie, Hyeje C. Sumajit, AbdelAziz R. Jalil, Subramanian Ramakrishnan, Lawrence J. Dooling, Yue Julia Wang, Jerome Irianto · 2023 · Molecular Biology of the Cell
  72. The genomic landscape of recurrent pancreatic cancer is modified by treatment
    Irene Y. Xie, Steve Gallinger · 2020 · Nature Reviews Gastroenterology & Hepatology
  73. Inhibition of Mitochondrial ATP Synthesis and Regulation of Oxidative Stress Based on {SbW8O30} Determined by Single‐Cell Proteomics Analysis
    Lige Gong, Wenqiao Ding, Ying Chen, Kai Yu, Changhong Guo, Baibin Zhou · 2021 · Angewandte Chemie
  74. A systematic evaluation of copy number alterations detection methods on real SNP array and deep sequencing data
    Fei Luo · 2019 · BMC Bioinformatics
  75. Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia
    Joshua David Cohen, Brenda B. Diergaarde, Nickolas Papadopoulos, Kenneth W. Kinzler, Robert E. Schoen · 2020 · Cancer Epidemiology Biomarkers & Prevention
  76. Cancer cells co-evolve with retrotransposons to mitigate viral mimicry
    Siyu Sun, Jungeui Hong, Eunae You, Kaloyan M. Tsanov, Jonathan A. Chacon-Barahona, Andrea Di Gioacchino, David Hoyos, Hao Li, Hua Liang Jiang, Bao-Han Ly et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex
    Marzieh Jamali, Erfaneh Barar, Jiaqi Shi · 2024 · International Journal of Molecular Sciences
  78. Navigating the complexities of pancreatic ductal adenocarcinoma: A review on therapeutic models and RAS inhibitors
    Sara Barrambana, Elena Zamorano-Domínguez, Vasiliki Liaki, Carmen E. Guerra · 2025 · Advanced Drug Delivery Reviews
  79. From lab to life: technological innovations in transforming cancer metastasis detection and therapy
    Soumya Basu, Satish Sasikumar, Subhayan Sur, Viniti Vaidya, Supriya Mohit Kheur, Samir Gupta, Amit Ranjan, Manash Kumar Paul, Neelu N Nawani, Aditi Bhat et al. · 2025 · Discover Oncology
  80. The genetic architecture of bone metastases: unveiling the role of epigenetic and genetic modifications in drug resistance
    Ahmad Dawalibi, Mohamad Adel Bakir, Khalid Said Mohammad · 2025 · Cancer Drug Resistance
  81. Clinical implications of the molecular characterization of intraductal papillary mucinous neoplasms of the pancreas
    Nicholas V. Peters, John W. Kunstman · 2021 · Journal of Cancer Metastasis and Treatment
  82. A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review
    Lauren M. Rosati, Megan N. Kummerlowe, Justin Poling, Amy Hacker‐Prietz, Amol Kumar Narang, Eun Ji Shin, Dung Thi Le, Elliot K. Fishman, Ralph H. Hruban, Stephen C. Yang et al. · 2017 · Oncotarget
  83. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma
    Lin Bao, Ye Zhao, Chenchen Liu, Qi Cao, Yu Huang, Ke Chen, Zhengshuai Song · 2020 · Journal of Cancer
  84. Pancreatic cancer epigenetics: adaptive metabolism reprograms starving primary tumors for widespread metastatic outgrowth
    Arnaldo Franco, Jeffrey Duryea, Oliver Gene McDonald · 2023 · Cancer and Metastasis Reviews
  85. Phenotypic, Genomic, and Transcriptomic Heterogeneity in a Pancreatic Cancer Cell Line
    Gengqiang Xie, Liting Zhang, Olalekan H. Usman, Sampath Kumar, Chaity Modak, Dhenu Patel, Megan Kavanaugh, Xian Mallory, Yue Julia Wang, Jerome Irianto · 2024 · Pancreas
  86. DNA methylation profile to aid in the diagnosis of pancreatic ductal adenocarcinoma and its role in disease progression
    Elena Grafenhorst, Teodor G. Calina, Mihnea Paul Dragomir · 2025 · Epigenomics
  87. The molecular logic of early metastasis in pancreatic cancer: crosstalk between tumor and microenvironment
    Andrea Costamagna, Ghiglione Noemi, Miriam Martini · 2025 · Frontiers in Cell and Developmental Biology
  88. Genomic evolution of pancreatic cancer at single-cell resolution
    Haochen Zhang, Palash Sashittal, Elias-Ramzey R. Karnoub, Akhil Jakatdar, Shigeaki Umeda, Jungeui Hong, Anne Marie Noronha, Agustin Cardenas, Amanda Erakky, Caitlin A. McIntyre et al. · 2026 · Nature Genetics
  89. Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO
    Alison B. Ross, Darvesh Gorhe, Jenny Kim Kim, Stefanie J. Hodapp, Lela DeVine, Karina M. Chan, Iok In Christine Chio, Marko Jovanović, Marina Ayres Pereira · 2024 · Cell Reports Methods
  90. Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes in Related Patients With Pancreatic Adenocarcinoma
    Jason M. Link, Shannon M. Liudahl, Courtney B. Betts, Shamilene Sivagnanam, Kenna R. Leis, Mary McDonnell, Carl Pelz, Brett Johnson, Kelly Jo Hamman, Dove Keith et al. · 2021 · JCO Precision Oncology
  91. Molecular characteristics of multifocal esophageal squamous cell carcinomas to discriminate multicentric origin from intramural metastasis
    Weihua Li, Na Cheng, Zitong Zhao, Bo Jian Zheng, Zhaoyang Yang, Yang Xu, Yang Washington Shao, Yongmei Song, Ning Lü, Liyan Xue · 2022 · The Journal of Pathology
  92. PDAC metastases show identical known driver gene mutations
    Iain Dickson · 2017 · Nature Reviews Gastroenterology & Hepatology
  93. New insights into the role of intra-tumor genetic heterogeneity in carcinogenesis: identification of complex single gene variance within tumors
    Bruce Gottlieb, Farbod Babrzadeh, Kathleen Klein Oros, Carlos Alvarado, Chunlin Wang, Baback Gharizadeh, Mark Basik, Celia M.T. Greenwood, Lenore K. Beitel, Mark A. Trifiro · 2018 · Journal of Cancer Metastasis and Treatment
  94. XLR-Net: Explainable AI-driven improved L 1 -regularized deep neural architecture for NSCLC biomarker identification
    Kountay Dwivedi, Ankit Rajpal, Sheetal Rajpal, Virendra Kumar, Manoj Agarwal, Naveen Kumar · 2023 · Computational Biology and Chemistry
  95. Omics Integration Analyses Reveal the Early Evolution of Malignancy in Breast Cancer
    Shamim Sarhadi, Ali Salehzadeh‐Yazdi, Mehdi Damaghi, Nosratollah Zarghami, Olaf Wolkenhauer A, Hedayatollah Hosseini · 2020 · Cancers
  96. Aminopyridine analogs selectively target metastatic pancreatic cancer
    Rana V. Smalling, Matthew E. Bechard, Jeff Duryea, Philip J. Kingsley, Evan R. Roberts, Lawrence J. Marnett, Daniel Bilbao, Shaun R. Stauffer, Oliver Gene McDonald · 2022 · Oncogene
  97. Epigenetic therapeutic strategies in pancreatic cancer
    Arturo Orlacchio, Stephen Muzyka, Tamas A. Gonda · 2024 · International review of cytology
  98. Immunohistochemical profiling of liver metastases and matched-pair analysis in patients with metastatic pancreatic ductal adenocarcinoma
    Thomas Held, Caroline Sophie Verbeke, Oliver Strobel, Wiktor Rutkowski, Christina Villard, Carlos Fernández Moro, Marco Del Chiaro, Markus Wolfgang Büchler, Rainer Lothar Heuchel, Matthias J. Löhr · 2019 · Pancreatology
  99. Circulating Tumour Cells
    Konstantinos L. Georgiadis, Kathryn Simpson, Mahmood Ayub, Gerard Brady, Juan W. Valle, Claus Jørgensen, Caroline Dive · 2017 · Springer eBooks
  100. Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
    Joyce K. Thompson, Filip Bednar · 2021 · Epigenomes